Protectus Medical Device
Private Company
Total funding raised: $500K
Overview
Protectus Medical Devices is a private medical technology company focused on mitigating the global needlestick injury crisis through its innovative safety syringe. The company's core product is a fully automatic, self-sheathing hypodermic syringe that passively activates upon withdrawal, complying with OSHA mandates and federal safety regulations. With FDA clearance in hand and a cost structure comparable to conventional syringes, Protectus aims to capture a meaningful share of the multi-billion dollar global syringe market by offering a superior safety profile. The company is led by an experienced CEO with a background in medical devices and corporate development.
Technology Platform
Patented automatic, self-sheathing safety mechanism for percutaneous devices utilizing a spring-biased sheath that passively locks upon needle withdrawal or loss of user control.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
The safety syringe market is competitive, dominated by large players like Becton Dickinson and Cardinal Health, which offer various manual and semi-automatic safety devices. Protectus differentiates itself by claiming to be the only fully automatic, self-sheathing syringe that meets the strict federal definition, offering a passive safety advantage. However, it must overcome the massive scale, brand recognition, and existing contracts of these incumbents.